Nat-Erlotinib 25 mg

Erlotinib 25 mg tablets are a targeted therapy used to manage certain types of cancer. This oral medication is designed to inhibit specific proteins that contribute to cancer cell growth.

Erlotinib is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by targeting the epidermal growth factor receptor (EGFR), which can help slow the progression of these cancers. Patients often wonder, 'What is erlotinib used for?' and the answer lies in its ability to interfere with the growth and spread of cancer cells.

Common effects of erlotinib may include skin rash, diarrhea, and fatigue. Some users also report appetite loss and dry skin. These effects can vary in intensity and duration among individuals.

Erlotinib should be handled with care, especially for those with pre-existing lung conditions. It is important to follow medical guidance regarding its use. Always store the medication as directed and keep it out of reach of children.

Erlotinib may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. It is advisable to consult a healthcare provider before combining erlotinib with other treatments. Alcohol and certain foods may also affect its efficacy.